HomeNewscoronavirus$100 as a Vaccine Incentive? Experiment Suggests It Can Pay Off

$100 as a Vaccine Incentive? Experiment Suggests It Can Pay Off

Last month, researchers randomly assigned unvaccinated respondents to see messages about financial incentives. Some people were asked about the chances they would get a vaccine if it came with a $25 cash payment; other people were asked about receiving $50 or $100.

May 04, 2021 / 17:59 IST
Story continues below Advertisement
COVID-19 Vaccine | Representative image
COVID-19 Vaccine | Representative image

What’s the best way to persuade the millions of Americans who are still unvaccinated against COVID-19 to get their shots?

Reassuring public service announcements about the vaccine’s safety and effectiveness have proliferated. But increasingly, people are realizing that it will take more than just information to sway the hesitant.

Story continues below Advertisement

In recent randomized survey experiments by the UCLA COVID-19 Health and Politics Project, two seemingly strong incentives have emerged.

Roughly a third of the unvaccinated population said a cash payment would make them more likely to get a shot. This suggests that some governors may be on the right track; West Virginia’s governor, Jim Justice, for example, recently announced the state would give young people $100 bonds if they got an inoculation.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show